[Skip to Navigation]
Observation
April 2017

Novel Application of High-Dose-Rate Brachytherapy for Severe, Recalcitrant Acrodermatitis Continua of Hallopeau

Author Affiliations
  • 1Department of Dermatology, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts
  • 2Division of Dermatology, The University of Arizona College of Medicine, Tucson
  • 3Division of Brachytherapy, Department of Radiation Oncology, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts
JAMA Dermatol. 2017;153(4):331-332. doi:10.1001/jamadermatol.2016.5142
Add or change institution
×